Altera Biosciences

Altera Biosciences is a preclinical-stage biotechnology company developing a universal donor cell platform to power the next generation of off-the-shelf allogeneic cell therapies. Altera Biosciences is Africa’s pioneering cell and gene therapy biotechnology startup, headquartered in Tshwane, South Africa. Founded by seasoned biotech entrepreneur Alexandra Miszewski and molecular medicine expert Professor Michael Pepper, the company is on a mission to solve one of regenerative medicine’s greatest challenges: immune rejection. Using cutting-edge gene silencing technology, Altera is developing a universal donor cell platform that effectively erases... Read more